Clinical Trials Directory

Trials / Completed

CompletedNCT04099173

A Brief Mindfulness-Based Intervention for Suicidal Ideation

A Randomized Pilot Study of a Brief Mindfulness-Based Intervention for Suicidal Ideation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
VA Salt Lake City Health Care System · Federal
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this study is to determine whether a Brief Mindfulness-Based Intervention for Suicidal Ideation (MB-SI) is feasible and safe to implement. The secondary aims are short and longer-term reduction in suicidal ideation (SI) and/or suicide-related behaviors (SRBs) as well as improvements in mindfulness and emotional regulation measures compared to Treatment as Usual (TAU).

Detailed description

The study feasibility will be assessed through participant enrollment and retention numbers. The safety be monitored by the study personnel and include reporting any adverse effects. The intervention fidelity will be aided by standardizing the intervention and ensuring study personnel has the appropriate trainings. Participants will completed questionnaires assessing their SI and SRB as well as mindfulness and emotional regulation measures at three time points (preintervention, immediately postintervention, and 1-month postintervention) and their results will be compared between MB-SI and TAU groups. Additionally, the comparisons will also be conducted for the Emergency Department (ED) admissions, Inpatient Psychiatric Unit (IPU) admissions, and psychiatric ED admissions.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBrief Mindfulness Based InterventionThis intervention will consist of four, 45 minute individual mindfulness training sessions (one session per day, over a range of 12 subsequent days) provided by a trained mindfulness facilitator.

Timeline

Start date
2019-09-01
Primary completion
2023-01-05
Completion
2023-01-05
First posted
2019-09-23
Last updated
2023-05-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04099173. Inclusion in this directory is not an endorsement.